Front Page - Latvijas Organiskās sintēzes institūts

The leading drug discovery and development centre in the Baltics

The study identifies potent SARS-CoV-2 inhibitors which could serve as a valuable starting point for further investigations

RISK-HUNT3R project launches: risk assessment of chemicals integrating human centric next generation testing strategies promoting the 3Rs

Synthesis of tryptophan precursors for protein NMR spectroscopy

When Eastern European Research Institutes Pull Together as a Team

Researchers design potent drug compound against malaria

Visible light‐mediated functionalization of selenocystine‐containing peptides

Electrochemical Generation of Hypervalent Bromine(III) Compounds

Studies prove the application of high‐sensitivity MAS NMR in vaccine design and formulation

Research

Services

Laboratories

Research in organic chemistry, pharmaceutical research, molecular biology and bioorganic chemistry

News

The study identifies potent SARS-CoV-2 inhibitors which could serve as a valuable starting point for further investigations

14/06/2021

The Covid-19 pandemic is one of the greatest challenges modern...

RISK-HUNT3R project launches: risk assessment of chemicals integrating human centric next generation testing strategies promoting the 3Rs

10/06/2021

RISK-HUNT3R is the new European effort hosting world-leading experts from...

Synthesis of tryptophan precursors for protein NMR spectroscopy

27/05/2021

Ansis Maleckis (Latvian Institute of Organic Synthesis), Iresha D. Herath ...

When Eastern European Research Institutes Pull Together as a Team

25/05/2021

The new A4L_ACTIONS project just started The kick-off conference of...

EU-OPENSCREEN: European high-capacity screening network

21/05/2021

EU-OPENSCREEN integrates high-capacity screening platforms throughout Europe, which jointly use...